BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25600448)

  • 1. Disseminated intravascular coagulation and immune hemolytic anemia, possibly Evans syndrome, after oxaliplatin and bevacizumab infusion for metastatic colon adenocarcinoma: a case report and literature review.
    Meng L; Romano A; Smith E; Macik G; Grosh WW
    Clin Colorectal Cancer; 2015 Mar; 14(1):e1-3. PubMed ID: 25600448
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer.
    Malkhasyan K; Halene S; Lacy J
    Clin Colorectal Cancer; 2015 Mar; 14(1):e9-e12. PubMed ID: 25446051
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation caused by advanced colon cancer successfully treated with SOX/bevacizumab].
    Suzuki H; Matsuoka N; Ushimaru Y; Kakimoto Y; Toyoda A; Endo Y; Murakami O; Kato Y; Inoue M; Kimura T; Matsuda Y; Sasakabe H
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):1013-6. PubMed ID: 25132036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.
    Ito I; Ito Y; Mizuno M; Suzuki Y; Yasuda K; Ozaki T; Kosugi T; Yasuda Y; Sato W; Tsuboi N; Maruyama S; Imai E; Matsuo S
    Clin Exp Nephrol; 2012 Jun; 16(3):490-4. PubMed ID: 22450906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer].
    Ogura T; Tajika M; Niwa Y; Kawai H; Kondo S; Sawaki A; Mizuno N; Hara K; Hijioka S; Nakamura M; Higuchi K; Goto H; Yamao K
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1712-9. PubMed ID: 21971145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
    Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
    Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical Response of Metastatic Colon Cancer to Chemotherapy with S-1 and Oxaliplatin - A Case Report].
    Morimoto T; Yata Y; Yonenaga Y; Hanaki K; Mise M; Higaside S; Kanda Y; Noda H
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):743-5. PubMed ID: 26199249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group.
    Hong YS; Lee SS; Kim KP; Lee JL; Kang YK; Shin SJ; Ahn JB; Jung KH; Im SA; Kim TY; Kim JH; Park YS; Kim TW
    Am J Clin Oncol; 2014 Feb; 37(1):19-23. PubMed ID: 23111359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion.
    Waddle M; Irvin M; Gupta E; Gibbs M; Kakar TS; Gannon NA; Arthurs JR; Fischer DL; Ailawadhi S
    Chemotherapy; 2017; 62(5):295-300. PubMed ID: 28505615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
    Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
    Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment continuation with a single mild partial splenic embolization for thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced colon cancer.
    Heianna J; Muto O; Miyauchi T; Endo W; Togashi A; Azama K; Murayama S
    Indian J Gastroenterol; 2016 May; 35(3):245-7. PubMed ID: 27230031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin-induced thrombotic thrombocytopenic purpura: case report and literature review.
    Niu J; Mims MP
    J Clin Oncol; 2012 Nov; 30(31):e312-4. PubMed ID: 22987080
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant bevacizumab in colon cancer: where did we go wrong?
    Seymour MT
    Lancet Oncol; 2012 Dec; 13(12):1176-7. PubMed ID: 23168364
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute renal failure related to oxaliplatin-induced intravascular hemolysis.
    Ulusakarya A; Misra S; Haydar M; Habert H; Castagne V; Gumus Y; Delmas-Marsalet B; Machover D
    Med Oncol; 2010 Dec; 27(4):1425-6. PubMed ID: 19565364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
    Shao YY; Hong RL
    Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
    Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
    Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literature.
    Noronha V; Burtness B; Murren J; Duffy TP
    Clin Colorectal Cancer; 2005 Nov; 5(4):283-6. PubMed ID: 16356307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
    Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
    Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
    Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
    Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia.
    Overman MJ; Ferrarotto R; Raghav K; George B; Qiao W; Machado KK; Saltz LB; Mazard T; Vauthey JN; Hoff PM; Hobbs B; Loyer EM; Kopetz S
    J Natl Cancer Inst; 2018 Aug; 110(8):888-894. PubMed ID: 29346573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.